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Abstract
Background: Diagnosis of tuberculous meningitis (TBM) is difficult. Rapid confirmatory diagnosis
is essential to initiate required therapy. There are very few published reports about the diagnostic
significance of 65 kD heat shock protein (hsp) in TBM patients, which is present in a wide range of
Mycobacterium tuberculosis species and elicits a cellular and humoral immune response. In the
present study we have conducted a prospective evaluation for the demonstration of 65 kD hsp
antigen in cerebrospinal fluid (CSF) of TBM patients, by indirect ELISA method using monoclonal
antibodies (mAb) against the 65 kD hsp antigen, for the diagnosis of TBM.
Methods: A total of 160 CSF samples of different groups of patients (confirmed TBM {n = 18},
clinically suspected TBM {n = 62}, non TBM infectious meningitis {n = 35} and non-infectious
neurological diseases {n = 45}) were analyzed by indirect ELISA method using mAb to 65 kD hsp
antigen. The Kruskal Wallis test (Non-Parametric ANOVA) with the Dunnett post test was used
for statistical analysis.
Results: The indirect ELISA method yielded 84% sensitivity and 90% specificity for the diagnosis
of TBM using mAb to 65 kD hsp antigen. The mean absorbance value of 65 kD hsp antigen in TBM
patients was [0.70 ± 0.23 (0.23–1.29)], significantly higher than the non-TBM infectious meningitis
group [0.32 ± 0.14 (0.12–0.78), P < 0.001] and also higher than the non-infectious neurological
disorders group [0.32 ± 0.13 (0.20–0.78), P  < 0.001]. A significant difference in the mean
absorbance of 65 kD hsp antigen was noted in the CSF of culture-positive TBM patients [0.94 ±
0.18 (0.54–1.29)] when compared with clinically suspected TBM patients [0.64 ± 0.20 (0.23–0.98),
P < 0.05].
Conclusion: The presence of 65 kD hsp antigen in the CSF of confirmed and suspected cases of
TBM would indicate that the selected protein is specific to M. tuberculosis and could be considered
as a diagnostic marker for TBM.
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Background
The world health organization estimates that there are
more than 8 million new cases of tuberculosis (TB) each
year [1,2]. Among tuberculosis, tuberculous meningitis
(TBM) has become more common with the emergence of
human immunodeficiency virus (HIV) infection [3,4].
TBM leads to multiple central nervous system (CNS) com-
plications and if untreated remains a major health prob-
lem in underdeveloped and developing countries.
Diagnosis of TBM remains problematic despite many new
advanced diagnostic methods. A reliable and rapid diag-
nostic test, which can be performed in any standard
pathology laboratory, can be of help in early definitive
diagnosis of TBM.
A number of studies have reported the use of various
methodologies for demonstration of Mycobacterium tuber-
culosis  antigens and antibodies in cerebrospinal fluid
(CSF) of TBM patients. Most of the antigens used in these
studies were either cell wall components or culture filtrate
proteins of M tuberculosis [5-8]. However, there are very
few published reports to detect the heat shock protein
(hsp) in CSF for diagnosis of TBM.
Various families of Hsps like Hsp90, Hsp70, Hsp65 and
Hsp10 have been shown to elicit strong immune
responses in the host during tuberculous infection [9,10].
Amongst these, one particular antigen 65 kD hsp
(Rv0440) is present in wide range of Mycobacterium tuber-
culosis species and is immunodominant which elicits cel-
lular and humoral immune responses [11-13]. This
protein is produced in response to host reaction during
infection and thus the more general term, stress protein
has been applied to this class of proteins [14]. 65 kD hsp
plays a dual role in cells, primarily as molecular chaper-
ones and also as immunodominant antigens upon infec-
tion in the host [10]. A study indicated that the level of
these proteins of M. tuberculosis increases by 1–10% under
conditions of stress which is likely to occur during tuber-
culous infection [15].
The quantitative measurement of 65 kD hsp antigen levels
in CSF samples of TBM patients may provide new insights
into the diagnostic role of 65 kD hsp in TBM infection. In
the present study, we have conducted a prospective labo-
ratory investigation for the detection of 65 kD hsp anti-
gen, in CSF of TBM patients by indirect ELISA method
using monoclonal antibodies (mAb) against the 65 kD
hsp antigen.
Methods
A total of 160 CSF samples of different group of patients,
which includes TBM (confirmed cases = 18, clinically sus-
pected cases = 62), non-TBM infectious meningitis (pyo-
genic meningitis = 25, viral meningitis = 10) and non-
infectious neurological disorders (n = 45, which includes
cases of stroke, headache etc) were analyzed in the present
study. Patients included in the study are those admitted to
the Neurology Department of Central India Institute of
Medical sciences (CIIMS). 65 kD hsp antigen estimation
was done in the CSF samples obtained before starting any
treatment in all cases of neurological disorders including
viral, bacterial, and mycobacterial meningitis. All patients
were grouped as follows:
Tuberculosis Meningitis (n = 80)
Confirmed cases (n = 18)
Presence of Mycobacterium tuberculosis in CSF by culture
Clinically suspected (n = 62)
This group included culture negative cases with all of the
following observations.
a) Sub-acute or chronic fever with features of meningeal
irritation such as headache, neck stiffness and vomiting
with or without other features of CNS involvement b) CSF
findings showing increased proteins, decreased glucose
(CSF: blood glucose ratio <0.5), and/or pleocytosis with
lymphocytic predominance c) Good clinical response to
antituberculous drugs. None of these TBM patients had
positive AFB staining.
Non-TBM infectious meningitis (n = 35)
This group included patients of pyogenic and viral menin-
gitis.
Pyogenic meningitis (n = 25)
Confirmed cases (n = 4)
Presence of pathogenic bacteria such as Staphylococcus sps,
Streptococcus sps, Haemophilus sps in CSF by staining and/or
culture
Clinically suspected (n = 21)
This group included culture negative cases with all the fol-
lowing observations:
a) Fever and/or signs of meningeal irritation (patients
who have undergone cranial surgery to treat tumor(s),
stroke, or head injury and who have received antibiotics),
OR High fever and/or signs of meningeal irritation with or
without other CNS manifestations (patients who received
broad-spectrum antibiotics). b) CSF findings showing
increased proteins, decreased glucose (CSF: blood glucose
ratio <0.2), and/or pleocytosis with a predominance of
polymorphonuclear cells; c) Good clinical response to
broad-spectrum antibiotics
Viral meningitis (n = 10)
Mainly caused by Enterovirus and Herpesvirus. This group
included suspected patients with following observations:BMC Neurology 2006, 6:34 http://www.biomedcentral.com/1471-2377/6/34
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a) Acute onset of fever and symptoms and signs of menin-
geal irritation. b) CSF findings showing mild increase in
protein, glucose often normal and pleocytosis, predomi-
nantly lymphocytic c) No clinical evidences of extra cra-
nial tuberculosis.
Non-infectious neurological disorders (n = 45)
-All other patients who had no evidence of CNS or extra
CNS bacterial or viral infections were grouped in the non-
infectious/control group. Patients included in this group
are of chronic intractable headache, status epileptics,
stroke etc.
The study was approved by the Institutional Ethics Com-
mittee of CIIMS, Nagpur.
Specimen
CSF sample was collected by standard lumbar puncture.
Approximately 3 ml of CSF was obtained. It was used for
total and differential cell count, biochemistry, and smear
for Gram's, India ink, and AFB staining and for detection
of 65 kD hsp antigen by indirect ELISA. All the samples
were stored at -20°C until further analysis.
Antibodies
The 65 kD monoclonal antibody to 65 kD hsp antigen
was obtained from Colorado State University, USA under
the TB Research Materials and Vaccine Testing Contract
(NO1-AI-75320) derived from Mycobacterium tuberculosis,
strain H37Rv, designated IT13. The secondary antibody
was rabbit anti rat obtained from Genei, Bangalore, India.
One-dimensional PAGE
CSF samples obtained from TBM and non TBM cases were
subjected to Sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE). SDS-PAGE was performed
with a vertical slab gel electrophoresis system (Broviga,
India) using the standard Laemmali method, [16]. 4%
stacking gel and 10% running gel were used. Electro-
phoresis was carried out at 250 volts/50 mAmps. Gels
were developed by staining with Coomassie brilliant blue
GR-250 and the protein profiles were then studied. Band
size (i.e., molecular weight) was estimated using molecu-
lar weight markers (Genei, Bangalore, India).
Immunoblotting assay
CSF proteins (35ug/lane) were separated by SDS-PAGE,
and transferred to Polyvinyledineflouride (PVDF) mem-
berane by electroblotting at 100 V for 3 hours The mem-
brane was wetted in 50%v/v methanol prior to
electroblotting and after electroblotting. The membrane
was then blocked with 0.5% bovine serum albumin (BSA)
in phosphate buffer saline (PBS) and 0.05% Tween 20
(PBS-T) for 60 min at 37°C. After blocking, the mem-
brane was washed with PBS-T (3times 10min each), and
probed with monoclonal antibody (1:2000 dilution in
PBS-T) generated against 65 kD hsp antigen and incu-
bated at 37°C for 60 min. The membrane was then
washed with PBS-T, followed by addition of affinity puri-
fied anti-rat IgG conjugated to horseradish peroxi-
dase(Genei, Bangalore, India) diluted 1:10,000 in PBS-T,
and incubated at 37°C for 60 min After incubation the
membrane was washed extensively with PBS-T followed
by addition of tetramethylbenzidine-hydrogen peroxide
(TMB/H2O2)as substrate and the antibody reactivity was
visualized.
Indirect ELISA for detection of 65 kD hsp antigen
Prior to patients sampling, the assay was standardized
using different concentration of 65 kD antigen (1–
1000ng/ml) in PBS-T (pH 7.2). After standardization,
wells of flat-bottom microtiter plates were coated with
100 ùl of CSF samples (1:5 dilution in PBS-T) of selected
groups and incubated for 90 min at 37°C. The wells were
then washed with PBS-T and blocked with 100 ùl of 0.5%
BSA in PBS-T at 37°C for 60 min. After blocking, mono-
clonal antibody generated against 65 kD hsp antigen was
added to all the wells (1:5,000 dilution in PBS-T) and
incubated at 37°C for 60 min. The wells were washed
with the PBS-T followed by addition of, 100 ùl of affinity
purified anti-rat IgG conjugated to horseradish peroxi-
dase(Genei, Bangalore, India) with 1:10,000 dilution in
PBS-T, and incubated at 37°C for 60 min. After incuba-
tion the wells were washed extensively with PBS-T fol-
lowed by addition of 100ul of TMB/H2O2 substrate and
incubated at room temperature for 10 min. The reaction
was stopped with addition of 100 ùl of 2.5 N H2SO4. The
absorbance of each well was read at 450 nm. Each sample
was tested in triplicate.
Statistical analysis
Results are expressed as mean ± SD with range. To com-
pare mean absorbance value of 65 kD hsp antigen among
the TBM, non-TBM infectious meningitis and non-infec-
tious neurological disorders, the Kruskal Wallis test (Non-
Parametric ANOVA) with the Dunnett post test was used.
A P value less than 0.05 was considered significant. A cut
off value of absorbance of 65 kD hsp antigen for TBM
patients was calculated using the mean plus SD of the
absorbance of 65 kD hsp antigen in the non-TBM neuro-
logical disorders group. The sensitivity (true positive rate)
for the test was calculated as: [the number of samples in
the TBM group with absorbance ≥ (mean + SD) of absorb-
ance in the non-infectious neurological disorders group
divided by the total number of samples in the TBM group]
× 100. The specificity (true negative rate) for the test was
calculated as: [the number of samples in the non-TBM
group with absorbance < (mean + SD) of the absorbance
in the non-infectious neurological disorders groupBMC Neurology 2006, 6:34 http://www.biomedcentral.com/1471-2377/6/34
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divided by the total number of samples in the non-TBM
group] × 100.
Results
The CSF samples of 160 patients admitted to the Neurol-
ogy Department of CIIMS hospital were grouped into
three different categories (TBM, non-TBM infectious men-
ingitis and non infectious neurological disorders) on the
basis of clinical observations and biochemical and patho-
logical analyses of CSF samples. Of these 18 were of con-
firmed TBM, 62 of suspected TBM, 35 of non-TBM
infectious meningitis {pyogenic meningitis (25) and viral
meningitis (10)} and 45 of non-infectious neurological
disorders.
The CSF proteins were separated (35ug total protein in
each lane) by SDS-PAGE and blotted on to PVDF mem-
brane. Figure. 1 depicts the one-dimensional PAGE and
Immunoblot analysis. Fig. 1a SDS-PAG electrophoreto-
gram of CSF samples. CSF of TBM patient (lane 1), shows
more protein expression as compared to CSF of non TBM
patient (lane 2). Fig 1b depicts immunoblotting with spe-
cific rabbit antibodies against 65 kD hsp antigen. The CSF
of TBM patient (lane 1) shows reactivity for 65 kD hsp
antigen, which was absent in case of non-TBM
patient(lane 2).
Different concentrations of 65 kD hsp antigen were
titrated with its monoclonal antibody and a standard
graph was plotted with the increasing concentration of
antigen. Figure. 2 show the increase in absorbance at 450
nm with increasing concentration of 65 kD hsp antigen
during the standardization of indirect ELISA method.
Table 1 depicts the demonstration of 65 kD hsp in CSF of
patients of TBM, non-TBM infectious meningitis and non
infectious neurological disorders by indirect ELISA
method using mAb specific to 65 kD hsp antigen. The CSF
positivity for 65 kD hsp antigen in case of confirmed and
clinically suspected patients was 100% (18/18) and 77%
(48/62) respectively, while the positivity for patients with
pyogenic meningitis was 8% (2/25) and viral meningitis
was 10% (1/10). In the non infectious neurological disor-
ders group, 11% (5/45) of patients had CSF positivity for
65 kD hsp antigen. Overall the indirect ELISA method
yielded 84% sensitivity and 90% specificity for the diag-
nosis of TBM using mAb to 65 kD hsp antigen. Cut-off
value was calculated using mean ± Standard deviation of
control group.
Table 2 depicts the mean absorbance with range and inter-
quartile range of the 65 kD hsp antigen in the CSF of TBM,
non TBM infectious and non TBM non infectious patients.
The data are expressed as mean ± Standard Deviation. The
mean absorbance value of 65 kD hsp antigen in TBM
patients was [0.70 ± 0.23 (0.23–1.29)] significantly
higher than the non-TBM infectious meningitis group
[0.32 ± 0.14 (0.12–0.78); P < 0.001]and also higher than
the non-infectious neurological disorders group [0.32 ±
0.13 (0.20–0.78); P < 0.001].
Figure 3 shows the box plot for demonstration of 65 kD
hsp antigen in CSF of culture positive and clinically sus-
pected TBM patients, non-TBM infectious meningitis
patients and non infectious neurological disorders
groups. The box plot shows 5th  and 95th percentiles
(bars), 75th and 25th percentiles (boxes) and median
(bars in boxes). N -numbers of individual in each group.
One-dimensional PAGE and Immunoblot Figure 1
One-dimensional PAGE and Immunoblot. Fig 1a SDS-PAG electrophoretogram of CSF samples. Lane (1) CSF of TBM patient, 
lane (2) CSF of non-TBM patient. Fig 1b Immunoblot analysis using specific rabbit antibodies against 65 kD antigen. Lane (1) 
CSF of TBM patient, lane (2) CSF of non-TBM patient.
a) b)
  1  2
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Discussion
TBM is often difficult to diagnose because of its diverse
clinical presentations which can mimic other clinical neu-
rological disorders like pyogenic meningitis, particularly
partially treated, other CNS infectious and non infectious
disorders [17,18]. Early confirmatory diagnosis of TBM is
difficult to establish because of its pleomorphic clinical
presentation [19,20]. Delayed diagnosis and treatment
may be associated with many serious CNS complications
[21]. The most commonly used laboratory method for the
definitive diagnosis of TBM is to demonstrate the presence
of tubercle bacilli either by smear and/or culture. How-
ever, direct smear methods are often negative in CSF sam-
ples and culturing of MTB takes 4–6 weeks [22,23]. Recent
methods such as those involving the amplification of bac-
terial DNA by the polymerase chain reaction and compa-
rable systems are incompletely assessed and not available
for widespread use in the developing countries. The sensi-
tivity of the PCR technique varies from 33% to 90% and
the specificity from 88% to 100% [24]. Various immu-
noassays such as antigen and/or antibody detection in
CSF samples have been developed with variable sensitivi-
ties and specificities [25-30]. Despite extensive work on
TBM, only few diagnostic tests are available [23,25,28]. A
reliable and rapid diagnostic test, which can be performed
in any standard pathology laboratory, can be of help in
diagnosis of TBM.
The 65 kD hsp antigen has received a great deal of atten-
tion recently because it appears to be one of the major
immunologically active mycobacterial antigens following
infection and is expressed at high levels by bacterial path-
ogens during adaptation for intracellular survival. In spite
of the interest generated in M.tuberculosis specific 65 kD
hsp, only limited attempts have been made to study this
protein in the diagnosis of tuberculous meningitis.
In the present study we have evaluated the 65 kD hsp anti-
gen activity in CSF samples obtained from patients of
TBM, non TBM infectious meningitis and non-infectious
neurological diseases, using monoclonal antibody against
65 kD hsp antigen by indirect ELISA method. The data of
this study demonstrates 100% and 77% positivity in the
CSF of culture-positive and clinically-suspected TBM
patients, respectively. False positive results were noted in
8 % of pyogenic meningitis and 10% of viral meningitis
cases. Overall the indirect ELISA method yielded 84% sen-
Table 1: Demonstration of 65 kD antigen in CSF of TBM, non TBM infectious and non TBM non infectious patients.
Groups Positivity for 65 kD hsp protein Negativity for 65 kD hsp protein
TBM (n = 80) 66 (84%) 14 (16%)
Suspected (n = 62) 48 (77%) 14 (23%)
Confirmed (n = 18) 18 (100%) -
Non-TBM (80) 8 (10%) 72 (90%)
Non TBM infectious meningitis (n = 35) 3 (14 %) 32 (86%)
Viral meningitis (n = 10) 01(10%) 09 (90%)
Pyogenic meningitis(n = 25) 02 (8%) 23 (92%)
Non-infectious neurological Disorders (45) 5 (11%) 40 (89%)
GBS(n = 12) 01 11
Stroke(n = 10) 04 06
Migraine(n = 08) - 08
Encephalopathy(n = 10) - 10
Fever(n = 05) - 05
Absorbance at 450 nm with increasing concentration of 65  kD antigen in the standardization procedure for indirect  ELISA method Figure 2
Absorbance at 450 nm with increasing concentration of 65 
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sitivity and 90% specificity for the diagnosis of TBM using
mAb to 65 kD hsp antigen.
Various families of hsp have been shown to elicit strong
immune responses in the host. Among these, the Hsp70
and Hsp65 classes have shown to play key roles in elicit-
ing immune responses [10]. Besides the diagnostic impor-
tance, this protein seems to have important role in
pathogenesis of tuberculosis. In a recent study Azov AG et
al[31] developed nested polymerase chain reaction (PCR)
protocols for detecting a Mycobacterium genus-specific 65
kD hsp sequence and the M. tuberculosis complex-specific
insertion sequence IS6110 in formalin-fixed and paraffin-
embedded sections with good sensitivity and specifi-
city[32]. To our knowledge there is no report of diagnostic
importance of this protein detection by ELISA in CSF spec-
imen. 65 kD hsp antigen detection using indirect ELISA
method is sensitive, specific, rapid and cost effective, and
could find practical application even in laboratories with
limited resources and technical expertise.
Conclusion
Our data suggests that the detection of 65 kD hsp antigen
in CSF of TBM patients can be useful for early diagnosis of
TBM. Detection of 65 kD hsp antigen using indirect ELISA
method is cost effective and could be an alternative to
other more expensive sophisticated techniques.
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Box plot for demonstration of 65 kD hsp in CSF of culture  positive (CP) and clinically suspected (CS) TBM patients,  non-TBM infectious meningitis (PM- pyogenic meningitis; VM- viral meningitis) and non infectious neurological disorders  groups (OTH) Figure 3
Box plot for demonstration of 65 kD hsp in CSF of culture 
positive (CP) and clinically suspected (CS) TBM patients, 
non-TBM infectious meningitis (PM- pyogenic meningitis; VM-
viral meningitis) and non infectious neurological disorders 
groups (OTH). The box plot show 5th and 95th percentiles 
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boxes). N – numbers of individual in each group.
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Table 2: Demonstration of mean absorbance with range and interquartile range of 65 kD antigen in the CSF of TBM, non TBM 
infectious and non TBM non infectious patients. The data are expressed as mean ± SD.
Patient group Absorbance Mean ± SD Range Interquartile Range
1. Tuberculous Meningitis (n = 80) 0.70 ± 0.23 0.23 – 1.29 0.57–1.05
Culture Positive (n = 18) 0.94 ± 0.18 0.54 – 1.29 0.78–1.05
Clinically Suspected (n = 62) 0.64 ± 0.20 0.23 – 0.98 0.57–0.78
2. Non TBM infectious meningitis 
(n = 35)
0.32 ± 0.14 0.12 – 0.78 0.22–0.35
Pyogenic meningitis (n = 25) 0.32 ± 0.16 0.12 – 0.78 0.22–0.35
Viral meningitis (n = 10) 0.33 ± 0.09 0.20 – 0.56 0.30–0.34
3. Non-infectious neurological 
disorders (n = 45)
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